Orf infection in a patient with stat1 gain-of-function
dc.contributor.author | Puel, Anne | |
dc.contributor.author | Casanova, Jean-Laurent | |
dc.contributor.buuauthor | Kılıç, Sara Şebnem | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0001-8571-2581 | tr_TR |
dc.contributor.researcherid | AAH-1658-2021 | tr_TR |
dc.contributor.scopusid | 34975059200 | tr_TR |
dc.date.accessioned | 2022-08-12T13:30:20Z | |
dc.date.available | 2022-08-12T13:30:20Z | |
dc.date.issued | 2015-01 | |
dc.description.abstract | Chronic Mucocutaneous Candidiasis (CMC) refers to a group of immunodeficiencies, characterized by persistent or recurrent infections of the skin, nails, and mucosae caused by Candida. It is typically caused by inborn errors of IL-17 immunity. Orf, also known as contagious ecthyma, is a zoonotic infection caused by a dermatotropic parapoxvirus that commonly infects sheep and goats; it is transmitted to humans through contact with an infected animal or fomites. While orf is usually a benign self-limiting illness, it can be progressive and even life-threatening in immune-compromised hosts. A 34-year-old man with autosomal dominant CMC due to a heterozygous STAT1 gain-of-function (GOF) mutation cut his hand with a knife during slaughter. Giant orf infection developed in 2 weeks. He was successfully treated by cidofovir injections every other week for 4 months. This is the first patient with severe orf in the context of a well-defined genetically identified PID: CMC and inborn error of IL-17 immunity due to a GOF STAT1 mutation. | en_US |
dc.identifier.citation | Kılıç, S. Ş. vd. (2015). "Orf infection in a patient with stat1 gain-of-function". Journal of Clinical Immunology, 35(1), 80-83. | tr_TR |
dc.identifier.endpage | 83 | tr_TR |
dc.identifier.issn | 0271-9142 | |
dc.identifier.issn | 1573-2592 | |
dc.identifier.issue | 1 | tr_TR |
dc.identifier.pubmed | 25367169 | tr_TR |
dc.identifier.scopus | 2-s2.0-84943588600 | tr_TR |
dc.identifier.startpage | 80 | tr_TR |
dc.identifier.uri | https://doi.org/10.1007/s10875-014-0111-7 | |
dc.identifier.uri | https://link.springer.com/article/10.1007/s10875-014-0111-7 | |
dc.identifier.uri | http://hdl.handle.net/11452/28191 | |
dc.identifier.volume | 35 | tr_TR |
dc.identifier.wos | 000348805600011 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer/Plenum Publishers | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.journal | Journal of Clinical Immunology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Chronic Mucocutaneous Candidiasis | en_US |
dc.subject | Orf infection | en_US |
dc.subject | STAT1 gain-of-function | en_US |
dc.subject | Primary immunodeficiency | en_US |
dc.subject | Immunology | en_US |
dc.subject | Virus infection | en_US |
dc.subject | Giant orf | en_US |
dc.subject | Immunity | en_US |
dc.subject | Autoantibodies | en_US |
dc.subject | Deficiency | en_US |
dc.subject | Mutations | en_US |
dc.subject | Lymphoma | en_US |
dc.subject | Humans | en_US |
dc.subject | Il-17a | en_US |
dc.subject.emtree | Cardiolipin antibody | en_US |
dc.subject.emtree | Caspofungin | en_US |
dc.subject.emtree | Cidofovir | en_US |
dc.subject.emtree | Cyanocobalamin | en_US |
dc.subject.emtree | Immunoglobulin G | en_US |
dc.subject.emtree | Immunoglobulin G2 | en_US |
dc.subject.emtree | Immunoglobulin G4 | en_US |
dc.subject.emtree | Immunoglobulin M | en_US |
dc.subject.emtree | Levothyroxine | en_US |
dc.subject.emtree | Posaconazole | en_US |
dc.subject.emtree | Pseudomonic acid | en_US |
dc.subject.emtree | STAT1 protein | en_US |
dc.subject.emtree | Virus DNA | en_US |
dc.subject.emtree | Antivirus agent | en_US |
dc.subject.emtree | Cytosine Interleukin 17 | en_US |
dc.subject.emtree | Phosphonic acid derivative | en_US |
dc.subject.emtree | STAT1 protein, human | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Autoimmune hemolytic anemia | en_US |
dc.subject.emtree | Autoimmune thyroiditis | en_US |
dc.subject.emtree | Brain artery aneurysm | en_US |
dc.subject.emtree | Candidiasis | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | CD4 lymphocyte count | en_US |
dc.subject.emtree | Chimera | en_US |
dc.subject.emtree | Computed tomographic angiography | en_US |
dc.subject.emtree | Contagious ecthyma | en_US |
dc.subject.emtree | Cytomegalovirus infection | en_US |
dc.subject.emtree | Gain of function mutation | en_US |
dc.subject.emtree | Genetic screening | en_US |
dc.subject.emtree | Hematopoietic stem cell transplantation | en_US |
dc.subject.emtree | Hepatitis | en_US |
dc.subject.emtree | Histopathology | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Hypothyroidism | en_US |
dc.subject.emtree | Lymphocyte count | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mucocutaneous Candidiasis | en_US |
dc.subject.emtree | Mycotic aneurysm | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Orf virus | en_US |
dc.subject.emtree | Papular rash | en_US |
dc.subject.emtree | Pernicious anemia | en_US |
dc.subject.emtree | Pneumonia | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Secondary infection | en_US |
dc.subject.emtree | Study | en_US |
dc.subject.emtree | Vitamin supplementation | en_US |
dc.subject.emtree | Analogs and derivatives | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Candidiasis, Chronic Mucocutaneous | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Dna mutational analysis | en_US |
dc.subject.emtree | Domestic sheep | en_US |
dc.subject.emtree | Ecthyma, contagious | en_US |
dc.subject.emtree | Genetics | en_US |
dc.subject.emtree | Immune deficiency | en_US |
dc.subject.emtree | Immunology | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Missense mutation | en_US |
dc.subject.emtree | Nucleotide sequence | en_US |
dc.subject.emtree | Zoonosis | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antiviral agents | en_US |
dc.subject.mesh | Base sequence | en_US |
dc.subject.mesh | Candidiasis, Chronic Mucocutaneous | en_US |
dc.subject.mesh | Cytosine | en_US |
dc.subject.mesh | DNA mutational analysis | en_US |
dc.subject.mesh | Ecthyma, contagious | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunologic deficiency syndromes | en_US |
dc.subject.mesh | Interleukin-17 | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mutation, missense | en_US |
dc.subject.mesh | Organophosphonates | en_US |
dc.subject.mesh | Sheep, domestic | en_US |
dc.subject.mesh | STAT1 transcription factor | en_US |
dc.subject.mesh | Zoonoses | en_US |
dc.subject.scopus | Contagious Ecthyma; Orf Virus; Parapoxvirus | en_US |
dc.subject.wos | Immunology | en_US |
dc.title | Orf infection in a patient with stat1 gain-of-function | en_US |
dc.type | Article | |
dc.wos.quartile | Q2 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: